{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:48:34Z","timestamp":1786996114259,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.radonc.2025.110873","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T10:17:41Z","timestamp":1743589061000},"page":"110873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Gross tumor volume increase and need for adaptive radiotherapy in pediatric-type diffuse high-grade glioma of the midline structures"],"prefix":"10.1016","volume":"207","author":[{"given":"Fasco","family":"van Ommen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toon","family":"van Genechten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam E.","family":"Willemsen-Bosman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Seravalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper","family":"van der Lugt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutger A.J.","family":"Nievelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Hulleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dannis G.","family":"van Vuurden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariette E.G.","family":"Kranendonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eelco W.","family":"Hoving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca A.W.","family":"Hoeben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert O.","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.110873_b0005","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2025.110873_b0010","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00401-015-1405-4","article-title":"Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers","volume":"129","author":"Korshunov","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.radonc.2025.110873_b0015","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2017.75.9308","article-title":"Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): a collaborative report from the International and European Society for Pediatric Oncology DIPG Registries","volume":"36","author":"Hoffman","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110873_b0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061512","article-title":"In vitro drug response and efflux transporters associated with drug resistance in pediatric high-grade glioma and diffuse intrinsic pontine glioma","volume":"8","author":"Veringa","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2025.110873_b0025","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/now101","article-title":"Pediatric high-grade glioma: biologically and clinically in need of new thinking","author":"Jones","year":"2016","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2025.110873_b0030","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/neuonc\/noac117","article-title":"The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies","volume":"24","author":"Persson","year":"2022","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2025.110873_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2023.100899","article-title":"Therapeutic avenues for targeting treatment challenges of diffuse midline gliomas","volume":"40","author":"Noon","year":"2023","journal-title":"Neoplasia"},{"key":"10.1016\/j.radonc.2025.110873_b0040","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.clon.2018.10.003","article-title":"Re-irradiation for paediatric tumours","volume":"31","author":"Tsang","year":"2019","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110873_b0045","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.adro.2019.03.009","article-title":"Role of radiation therapy in the management of diffuse intrinsic pontine glioma: a systematic review","volume":"4","author":"Gallitto","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110873_b0050","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijrobp.2022.01.054","article-title":"Hypofractionated radiation therapy for diffuse intrinsic pontine glioma: a noninferiority randomized study including 253 children","volume":"113","author":"Zaghloul","year":"2022","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110873_b0055","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00066-017-1218-6","article-title":"Concurrent radiotherapy with temozolomide vs. concurrent radiotherapy with a cisplatinum-based polychemotherapy regimen","volume":"194","author":"Seidel","year":"2018","journal-title":"Strahlentherapie und Onkol"},{"key":"10.1016\/j.radonc.2025.110873_b0060","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijrobp.2012.04.006","article-title":"Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched-cohort analysis","volume":"85","author":"Janssens","year":"2013","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110873_b0065","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0360-3016(98)00501-X","article-title":"There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int","volume":"43","author":"Mandell","year":"1999","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110873_b0070","series-title":"Modern Radiation Oncology: Classic Literature and Current Management","first-page":"104","article-title":"Primary brain tumors of the posterior fossa","author":"Salazar","year":"1978"},{"key":"10.1016\/j.radonc.2025.110873_b0075","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/0360-3016(85)90244-5","article-title":"Pediatric brain stem tumors: patterns of treatment failure and their implications for radiotherapy","volume":"11","author":"Halperin","year":"1985","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110873_b0080","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/nop\/npu022","article-title":"Management of high-grade gliomas in the pediatric patient: Past, present, and future","volume":"1","author":"Vanan","year":"2014","journal-title":"Neuro-Oncology Pract"},{"key":"10.1016\/j.radonc.2025.110873_b0085","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/neuonc\/noad258","article-title":"Evolving concepts in margin strategies and adaptive radiotherapy for glioblastoma: a new future is on the horizon","volume":"26","author":"Tseng","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2025.110873_b0090","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.ijrobp.2019.11.020","article-title":"Defining optimal target volumes of conformal radiation therapy for diffuse intrinsic pontine glioma","volume":"106","author":"Tinkle","year":"2020","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110873_b0095","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2016.12.007","article-title":"Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: a matched-cohort analysis on behalf of the SIOP-E-HGG\/DIPG working group","volume":"73","author":"Janssens","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2025.110873_b0100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11060-016-2151-8","article-title":"Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma","volume":"129","author":"Carceller","year":"2016","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2025.110873_b0105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.radonc.2021.04.001","article-title":"Evolution of the gross tumour volume extent during radiotherapy for glioblastomas","volume":"160","author":"Bernchou","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110873_b0110","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-024-10855-9","article-title":"Pediatric diffuse intrinsic pontine glioma radiotherapy response prediction: MRI morphology and T2 intensity-based quantitative analyses","author":"Yu","year":"2024","journal-title":"Eur Radiol"},{"key":"10.1016\/j.radonc.2025.110873_b0115","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ijrobp.2008.01.050","article-title":"Hearing loss after radiotherapy for pediatric brain tumors: effect of cochlear dose","volume":"72","author":"Hua","year":"2008","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110873_b0120","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ijrobp.2009.02.091","article-title":"Radiation dose\u2013volume effects in the brain","volume":"76","author":"Lawrence","year":"2010","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110873_b0125","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.radonc.2015.01.016","article-title":"Organs at risk in the brain and their dose-constraints in adults and in children: a radiation oncologist\u2019s guide for delineation in everyday practice","volume":"114","author":"Scoccianti","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110873_b0130","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1200\/JCO.2018.78.1492","article-title":"Endocrine deficiency as a function of radiation dose to the hypothalamus and pituitary in pediatric and young adult patients with brain tumors","volume":"36","author":"Vatner","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110873_b0135","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.ijrobp.2018.12.004","article-title":"Lens dose-response prediction modeling and cataract incidence in patients with retinoblastoma after lens-sparing or whole-eye radiation therapy","volume":"103","author":"Nguyen","year":"2019","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110873_b0140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1200\/JCO.21.01480","article-title":"Association between brain substructure dose and cognitive outcomes in children with medulloblastoma treated on SJMB03: a step toward substructure-informed planning","volume":"40","author":"Acharya","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110873_b0145","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/0360-3016(93)90548-A","article-title":"Radiation therapy oncology group: radiosurgery quality assurance guidelines","volume":"27","author":"Shaw","year":"1993","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110873_b0150","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0360-3016(96)00601-3","article-title":"A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: application to the prostate","volume":"37","author":"Riet","year":"1997","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110873_b0155","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/153303460400300308","article-title":"The impact of mid-treatment MRI on defining boost volumes in the radiation treatment of glioblastoma multiforme","volume":"3","author":"Manon","year":"2004","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.radonc.2025.110873_b0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3857\/roj.2021.00542","article-title":"Limited field adaptive radiotherapy for glioblastoma: changes in target volume and organ at risk doses","volume":"40","author":"\u015eenkesen","year":"2022","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.radonc.2025.110873_b0165","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ijrobp.2020.10.002","article-title":"Quantitating interfraction target dynamics during concurrent chemoradiation for glioblastoma: a prospective serial imaging study","volume":"109","author":"Stewart","year":"2021","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110873_b0170","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijrobp.2020.08.036","article-title":"Adaptive proton therapy for pediatric patients: improving the quality of the delivered plan with on-treatment MRI","volume":"109","author":"Acharya","year":"2021","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110873_b0175","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.semradonc.2019.02.004","article-title":"Practical clinical workflows for online and offline adaptive radiation therapy","volume":"29","author":"Green","year":"2019","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110873_b0180","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ijrobp.2020.10.021","article-title":"Adaptive radiation therapy (ART) strategies and technical considerations: a state of the ART review from NRG oncology","volume":"109","author":"Glide-Hurst","year":"2021","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110873_b0185","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11060-023-04505-1","article-title":"Anatomical changes in resection cavity during brain radiotherapy","volume":"165","author":"Willems","year":"2023","journal-title":"J Neurooncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025001689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025001689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T12:19:05Z","timestamp":1748002745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025001689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":37,"alternative-id":["S0167814025001689"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110873","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gross tumor volume increase and need for adaptive radiotherapy in pediatric-type diffuse high-grade glioma of the midline structures","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110873","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110873"}}